• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用肝细胞特异性标志物肝细胞石蜡1和多克隆抗癌胚抗原对肝母细胞瘤进行免疫组织化学评估。

Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen.

作者信息

Fasano M, Theise N D, Nalesnik M, Goswami S, Garcia de Davila M T, Finegold M J, Greco M A

机构信息

Department of Pathology, New York University Medical Center, New York 10016, USA.

出版信息

Mod Pathol. 1998 Oct;11(10):934-8.

PMID:9796718
Abstract

The distinction of hepatoblastoma, especially the embryonal type, from other small, round-cell tumors of childhood can sometimes be difficult. Polyclonal anticarcinoembryonic antigen (pCEA) and Hepatocyte Paraffin 1 (Hep Par 1) are immunohistochemical markers that are useful in the diagnosis of hepatocellular carcinomas. We immunohistochemically studied pCEA, monoclonal CEA (mCEA), and Hep Par 1 on 12 hepatoblastomas (3 fetal type, 2 embryonal type, and 7 mixed epithelial type). In addition, we studied the expression of Hep Par 1 on 27 other selected childhood tumors, including 1 hepatocellular carcinoma, 5 germ-cell tumors, 4 peripheral neuroectodermal tumors/Ewing's sarcomas, 3 rhabdomyosarcomas, 5 neuroblastomas, 2 rhabdoid tumors, 3 lymphomas, and 4 Wilms' tumors. All of the hepatoblastomas expressed Hep Par 1 with a characteristic granular intracytoplasmic pattern that was generally less intense in embryonal-type than in fetal-type hepatoblastomas, perhaps reflecting the degree of hepatocyte differentiation. All of the fetal-type hepatoblastomas expressed pCEA with both an intracytoplasmic and bile canalicular pattern. Embryonal type hepatoblastomas were more likely to be pCEA negative or to show focal or no canalicular pattern of expression, again possibly reflecting the degree of hepatocyte differentiation. All of the hepatoblastomas were mCEA negative. All of the nonhepatoblastomas were Hep Par 1 negative, except for the one hepatocellular carcinoma in this study, which was Hep Par 1 positive. We conclude that Hep Par 1 and pCEA are useful markers for hepatoblastomas, as they have been shown to be in hepatocellular carcinomas.

摘要

肝母细胞瘤,尤其是胚胎型,与儿童期其他小圆形细胞肿瘤的鉴别有时会很困难。多克隆癌胚抗原(pCEA)和肝细胞石蜡1(Hep Par 1)是有助于诊断肝细胞癌的免疫组化标志物。我们对12例肝母细胞瘤(3例胎儿型、2例胚胎型和7例混合上皮型)进行了pCEA、单克隆CEA(mCEA)和Hep Par 1的免疫组化研究。此外,我们还研究了Hep Par 1在27例其他选定的儿童肿瘤中的表达,包括1例肝细胞癌、5例生殖细胞肿瘤、4例外周神经外胚层肿瘤/尤因肉瘤、3例横纹肌肉瘤、5例神经母细胞瘤、2例横纹肌样瘤、3例淋巴瘤和4例肾母细胞瘤。所有肝母细胞瘤均表达Hep Par 1,呈特征性的颗粒状胞浆模式,胚胎型肝母细胞瘤的表达强度通常低于胎儿型,这可能反映了肝细胞的分化程度。所有胎儿型肝母细胞瘤均表达pCEA,呈胞浆内和胆小管模式。胚胎型肝母细胞瘤更可能pCEA阴性或呈局灶性或无胆小管模式表达,同样可能反映了肝细胞的分化程度。所有肝母细胞瘤均为mCEA阴性。除本研究中的1例肝细胞癌Hep Par 1阳性外,所有非肝母细胞瘤均为Hep Par 1阴性。我们得出结论,Hep Par 1和pCEA是肝母细胞瘤的有用标志物,正如它们在肝细胞癌中所显示的那样。

相似文献

1
Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen.使用肝细胞特异性标志物肝细胞石蜡1和多克隆抗癌胚抗原对肝母细胞瘤进行免疫组织化学评估。
Mod Pathol. 1998 Oct;11(10):934-8.
2
Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.胃肠道肝样腺癌中肝细胞石蜡1抗体的免疫反应性
Am J Clin Pathol. 2001 May;115(5):689-94. doi: 10.1309/5C2C-FP3H-GE7Q-2XJ5.
3
Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.肝细胞癌、胆管癌和转移性腺癌的免疫组织化学比较特征
Hum Pathol. 2002 Dec;33(12):1175-81. doi: 10.1053/hupa.2002.130104.
4
Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.免疫过氧化物酶染色作为肝细胞癌的诊断辅助手段。
Mod Pathol. 1989 Jan;2(1):8-12.
5
Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.肝细胞石蜡1单克隆抗体在皮肤转移性肿瘤中的免疫反应性
Am J Clin Pathol. 2004 Jul;122(1):85-9. doi: 10.1309/1GUH-U5LK-2A82-JTJR.
6
Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.抗肝细胞克隆OCH1E5(Hep Par 1)在肝肿瘤组织学评估中的应用。
Indian J Pathol Microbiol. 2006 Jul;49(3):341-4.
7
A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.比较CD10与pCEA、MOC-31及肝细胞用于鉴别肝脏恶性肿瘤。
Mod Pathol. 2002 Dec;15(12):1279-87. doi: 10.1097/01.MP.0000037312.69565.24.
8
Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.肝细胞石蜡1抗体无法区分具有肝样分化的原发性卵巢肿瘤与转移性肝细胞癌。
Int J Gynecol Pathol. 2004 Jan;23(1):58-64. doi: 10.1097/01.pgp.0000101141.31270.a1.
9
Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.人正常组织和肿瘤组织中肝细胞石蜡1的表达:对3940份组织样本的组织芯片分析
Am J Clin Pathol. 2004 Nov;122(5):721-7. doi: 10.1309/KC09-YTF2-M4DL-UYQ6.
10
Hepatoblastoma.肝母细胞瘤
Semin Diagn Pathol. 1994 May;11(2):136-43.

引用本文的文献

1
Hepatocyte paraffin 1 and arginase-1 are effective panel of markers in HBV-related HCC diagnosis in fine-needle aspiration specimens.在细针穿刺标本中,肝细胞石蜡 1 和精氨酸酶-1 是乙型肝炎病毒相关 HCC 诊断的有效标志物组合。
BMC Res Notes. 2020 Aug 20;13(1):388. doi: 10.1186/s13104-020-05230-y.
2
Study of liver in HBV-related hepatocellular carcinoma: Stereology shows quantitative differences in liver structure.乙肝相关肝细胞癌中肝脏的研究:体视学显示肝脏结构存在定量差异。
Eur J Histochem. 2018 Sep 18;62(3):2950. doi: 10.4081/ejh.2018.2950.
3
Hepatocellular carcinoma - an unusual metastatic presentation on the chest wall.
肝细胞癌——一种不寻常的胸壁转移表现。
Clin Exp Hepatol. 2016 Feb;1(4):133-135. doi: 10.5114/ceh.2015.58042. Epub 2016 Feb 25.
4
Hepatocyte Paraffin 1 Immunoreactivity in Early Colon Carcinogenesis.早期结肠癌发生过程中肝细胞石蜡切片1的免疫反应性
Gastroenterology Res. 2009 Oct;2(5):277-281. doi: 10.4021/gr2009.10.1313. Epub 2009 Sep 20.
5
Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).肝癌发生中新参与者的鉴定:使用组织微阵列(TMA)的局限性与机遇
Microarrays (Basel). 2014 Apr 15;3(2):91-102. doi: 10.3390/microarrays3020091.
6
Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma.肝细胞癌的组织和血清相关生物标志物
Biomark Cancer. 2016 Jul 4;8(Suppl 1):37-55. doi: 10.4137/BIC.S34413. eCollection 2016.
7
Immunohistochemical features of the gastrointestinal tract tumors.胃肠道肿瘤的免疫组织化学特征。
J Gastrointest Oncol. 2012 Sep;3(3):262-84. doi: 10.3978/j.issn.2078-6891.2012.019.
8
Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.精氨酸酶-1:一种新的肝细胞及肝细胞肿瘤免疫组化标志物。
Am J Surg Pathol. 2010 Aug;34(8):1147-54. doi: 10.1097/PAS.0b013e3181e5dffa.
9
Immunohistochemical characterization of canine intestinal epithelial and mesenchymal tumours with a monoclonal antibody to hepatocyte paraffin 1 (Hep Par 1).用抗肝细胞石蜡1(Hep Par 1)单克隆抗体对犬肠道上皮和间充质肿瘤进行免疫组织化学特征分析。
Histochem J. 2002 Aug-Sep;34(8-9):397-401. doi: 10.1023/a:1023683404230.
10
cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.cDNA阵列和免疫组织化学鉴定肝细胞癌中CD10/普通急性淋巴细胞白血病抗原的表达
Am J Pathol. 2001 Oct;159(4):1415-21. doi: 10.1016/S0002-9440(10)62528-X.